This protocol is judged by an institutional evaluation board, an independent team that evaluations any clinical trials involving individuals. If a review entails a Schedule I drug, once the board approves the protocol as ethical, the scientists really have to apply for an investigational new drug (IND) quantity from the FDA.Consumers noted minimal